Salta al contenuto principale

Per favore
selezionare il paese

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

Selezionando la visualizzazione internazionale, l'utente dichiara di risiedere al di fuori degli Stati Uniti e di voler visualizzare le informazioni sui prodotti internazionali di DiaSorin Molecular. Questo materiale è destinato esclusivamente ai visitatori internazionali (non statunitensi) del sito.

Ai sensi delle Linee Guida del Ministero della Salute del 28/03/2013 in materia di pubblicità sanitaria relativa a dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici, si informa che le informazioni contenute in questo sito e alle quali si accede sono destinate esclusivamente agli operatori professionali.

Direct links

Mycoplasma pneumoniae Diagnostic Solution

Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Mycoplasma pneumoniae, just like Chlamydia pneumoniae and Legionella pneumophila infections, is often the source. The correct identification of the etiological agent causing CAP, therefore, can positively support clinical treatment decisions.

Diasorin aids the differential serological diagnosis of Mycoplasma pneumoniae by providing high-quality, fully automated, assays for IgG and IgM antibodies detection. These same tests can also help differentiate between acute and past infections.

LIAISON® XL

LIAISON®Mycoplasma Pneumoniae IgG

Automated CLIA assay for the semi-quantitative determination of specific IgG antibodies to Mycoplasma pneumoniae in human serum or plasma samples.

LIAISON® XL

LIAISON®Mycoplasma Pneumoniae IgM

Automated CLIA assay for the qualitative determination of specific IgM antibodies to Mycoplasma pneumoniae in human serum or plasma samples.

Indications for use

Diagnosis

Detection of antibodies against Mycoplasma pneumoniae

Target patient

Adults and children

Use area

Pediatric medicine, general medicine, respiratory infections

Test Immunodiagnostico per la diagnosi delle infezioni da Micoplasmosi - Diasorin

Background

The clinical manifestations of Mycoplasma pneumoniae infections are mainly limited to the respiratory tract, but the infection can also affect other organs. Furthermore, children are infected more often than adults.

Because the disease has an insidious onset with malaise, myalgia, sore throat or headache and increasing chest symptoms, detection of specific IgG and IgM antibodies against Mycoplasma pneumoniae is the primary diagnostic tool for acute Mycoplasma pneumoniae respiratory disease. 

To be used on

Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.

Strumento di Immunodiagnostica per grandi laboratori LIAISON® XL - Diasorin

LIAISON® XL

Designed for large laboratories. Fuse the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation. 

Discover more

More details about our diagnostic solutions

Login to Dialog for additional resources

Login to our repository for instructions for use and user manuals, assay information, protocols and much more.

Dialog

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support

All the products in this family

Discover the range of specialty tests available

Discover more